{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:21:37Z","timestamp":1771050097704,"version":"3.50.1"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI119554"],"award-info":[{"award-number":["R01AI119554"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI063256"],"award-info":[{"award-number":["R01AI063256"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM60655"],"award-info":[{"award-number":["GM60655"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00227","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T04:25:35Z","timestamp":1531196735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation"],"prefix":"10.3389","volume":"8","author":[{"given":"Jesus A.","family":"Romo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Esqueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen. P.","family":"Saville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Lopez-Ribot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1128\/microbiolspec.VMBF-0030-2016","article-title":"Candida-bacteria interactions: their impact on human disease","volume":"4","author":"Allison","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1128\/AAC.47.11.3657-3659.2003","article-title":"Antifungal combinations against Candida albicans biofilms in vitro","volume":"47","author":"Bachmann","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2165\/00003495-200565110-00002","article-title":"Antifungal combination therapy: clinical potential","volume":"65","author":"Baddley","year":"2005","journal-title":"Drugs"},{"key":"B4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nrd3845","article-title":"Reducing safety-related drug attrition: the use of in vitro pharmacological profiling","volume":"11","author":"Bowes","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B6","doi-asserted-by":"publisher","first-page":"165r","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/cmi.12091","article-title":"Two unlike cousins: Candida albicans and C. glabrata infection strategies","volume":"15","author":"Brunke","year":"2013","journal-title":"Cell Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1567-1364.2009.00533.x","article-title":"Purification and germination of Candida albicans and Candida dubliniensis chlamydospores cultured in liquid media","volume":"9","author":"Citiulo","year":"2009","journal-title":"FEMS Yeast Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nchembio.2007.24","article-title":"Targeting virulence: a new paradigm for antimicrobial therapy","volume":"3","author":"Clatworthy","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mimet.2015.02.004","article-title":"Current methods for identifying clinically important cryptic Candida species","volume":"111","author":"Criseo","year":"2015","journal-title":"J. Microbiol. Methods"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/femsyr\/fov111","article-title":"Biofilm formation in Candida glabrata: What have we learnt from functional genomics approaches?","author":"d'enfert","year":"2016","journal-title":"FEMS Yeast Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16092","DOI":"10.1038\/nmicrobiol.2016.92","article-title":"Drug resistance in eukaryotic microorganisms","volume":"1","author":"Fairlamb","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.1305982110","article-title":"Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis","volume":"110","author":"Fazly","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/apc.1998.12.359","article-title":"Vaginal candidiasis: review and role of local mucosal immunity","volume":"12","author":"Fidel","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/EC.00215-12","article-title":"Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans","volume":"11","author":"Flowers","year":"2012","journal-title":"Eukaryotic Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","article-title":"Targeting virulence: a new paradigm for antifungals","volume":"14","author":"Gauwerky","year":"2009","journal-title":"Drug Discov. Today"},{"key":"B17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1099\/00221287-144-4-829","article-title":"Candida dubliniensis: phylogeny and putative virulence factors","volume":"144","author":"Gilfillan","year":"1998","journal-title":"Microbiology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jac\/11.5.427","article-title":"The fractional inhibitory concentration (FIC) index as a measure of synergy","volume":"11","author":"Hall","year":"1983","journal-title":"J. Antimicrob. Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4155\/fmc.09.51","article-title":"In vitro safety pharmacology profiling: what else beyond hERG?","volume":"1","author":"Hamon","year":"2009","journal-title":"Future Med. Chem."},{"key":"B21","first-page":"761","article-title":"Strategies for antimicrobial susceptibility testing of fastidious aerobic bacteria","volume":"49","author":"Hindler","year":"1983","journal-title":"Am. J. Med. Technol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-4757-9206-5_7","article-title":"Non-traditional approaches for quality control of antimicrobial susceptibility tests","volume":"349","author":"Hindler","year":"1994","journal-title":"Adv. Exp. Med. Biol."},{"key":"B23","first-page":"5.18.11","article-title":"Antimicrobial susceptibility testing","volume-title":"Clinical Microbiology Procedures Handbook","author":"Hindler","year":"1995"},{"key":"B24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1139\/m85-132","article-title":"Morphological studies of N-acetylglucosamine induced germ tube formation by Candida albicans","volume":"31","author":"Hubbard","year":"1985","journal-title":"Can. J. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrg3922","article-title":"Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms","volume":"16","author":"Hughes","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3201\/eid1001.030119","article-title":"Fungal biofilms and drug resistance","volume":"10","author":"Jabra-Rizk","year":"2004","journal-title":"Emerging Infect. Dis."},{"key":"B27","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/JCM.32.10.2448-2459.1994","article-title":"Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae","volume":"32","author":"Jorgensen","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.chom.2013.10.016","article-title":"Candida albicans: adapting to succeed","volume":"14","author":"Kadosh","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen","volume":"49","author":"Kim","year":"2011","journal-title":"J. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/CMR.17.2.255-267.2004","article-title":"Candida infections of medical devices","volume":"17","author":"Kojic","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1128\/EC.00164-13","article-title":"Comparative evolution of morphological regulatory functions in Candida species","volume":"12","author":"Lackey","year":"2013","journal-title":"Eukaryotic Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/00362177585190271","article-title":"An amino acid liquid synthetic medium for the development of mycellal and yeast forms of Candida albicans","volume":"13","author":"Lee","year":"1975","journal-title":"Med. Mycol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1126\/science.7992058","article-title":"Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog","volume":"266","author":"Liu","year":"1994","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2005.06.020","article-title":"Candida albicans biofilms: more than filamentation","volume":"15","author":"Lopez-Ribot","year":"2005","journal-title":"Curr. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1128\/JCM.40.9.3135-3139.2002","article-title":"Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole","volume":"40","author":"Martinez","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1128\/EC.00252-07","article-title":"Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells","volume":"6","author":"Martins","year":"2007","journal-title":"Eukaryotic Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"B40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.idc.2015.10.013","article-title":"Invasive candidiasis","volume":"30","author":"McCarty","year":"2016","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1128\/JCM.01574-07","article-title":"Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans","volume":"46","author":"McManus","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1365-2958.2007.05965.x","article-title":"Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis","volume":"66","author":"Moran","year":"2007","journal-title":"Mol. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond","volume":"9","author":"Ostrosky-Zeichner","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3791\/2437","article-title":"Microtiter dish biofilm formation assay","volume":"30","author":"O'Toole","year":"2011","journal-title":"J. Vis. Exp."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1128\/AAC.45.10.2676-2684.2001","article-title":"Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients","volume":"45","author":"Perea","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"B48","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/npjbiofilms.2015.12","article-title":"A novel small molecule inhibitor of biofilm formation, filamentation and virulence with low potential for the development of resistance","volume":"1","author":"Pierce","year":"","journal-title":"NPJ Biofilms Microb."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1517\/17460441.2013.807245","article-title":"Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs","volume":"8","author":"Pierce","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"B50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1128\/microbiolspec.MB-0007-2014","article-title":"From biology to drug development: new approaches to combat the threat of fungal biofilms","volume":"3","author":"Pierce","year":"","journal-title":"Microbiol. Spectr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.coph.2013.08.008","article-title":"Antifungal therapy with an emphasis on biofilms","volume":"13","author":"Pierce","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-3-642-53833-9_13","article-title":"Inhibition of fungal biofilms","volume-title":"Antibiofilm Agents","author":"Pierce","year":"2014"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat. Protoc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3791\/2287","article-title":"A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms","volume":"21","author":"Pierce","year":"2010","journal-title":"J. Vis. Exp"},{"key":"B55","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1128\/EC.00062-15","article-title":"Characterization of virulence-related phenotypes in Candida species of the CUG clade","volume":"14","author":"Priest","year":"2015","journal-title":"Eukaryotic Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: an update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryotic Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1128\/JCM.39.9.3234-3240.2001","article-title":"Biofilm formation by Candida dubliniensis","volume":"39","author":"Ramage","year":"","journal-title":"J. Clin. Microbiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms","volume":"45","author":"Ramage","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B59","first-page":"163","article-title":"Characteristics of biofilm formation by Candida albicans","volume":"18","author":"Ramage","year":"","journal-title":"Rev. Iberoam. Micol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"B61","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1369-5274(03)00081-X","article-title":"Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts","volume":"6","author":"Romani","year":"2003","journal-title":"Curr. Opin. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00281-014-0464-2","article-title":"The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism","volume":"37","author":"Romani","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e01991-17","DOI":"10.1128\/mBio.01991-17","article-title":"Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation","volume":"8","author":"Romo","year":"2017","journal-title":"MBio"},{"key":"B64","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/0022034515625222","article-title":"Innate immunity and saliva in Candida albicans-mediated oral diseases","volume":"95","author":"Salvatori","year":"2016","journal-title":"J. Dent. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options","volume":"62","author":"Sardi","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"w14281","DOI":"10.4414\/smw.2016.14281","article-title":"Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med. Wkly."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1128\/AAC.00740-08","article-title":"Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains","volume":"52","author":"Schubert","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1128\/EC.05030-11","article-title":"Modulation of morphogenesis in Candida albicans by various small molecules","volume":"10","author":"Shareck","year":"2011","journal-title":"Eukaryotic Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1139\/m80-004","article-title":"Germ tube induction in Candida albicans","volume":"26","author":"Shepherd","year":"1980","journal-title":"Can. J. Microbiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1128\/EC.00291-09","article-title":"Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model","volume":"9","author":"Spiering","year":"2010","journal-title":"Eukaryot Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"key":"B73","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.fgb.2006.11.014","article-title":"Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans","volume":"44","author":"Stokes","year":"2007","journal-title":"Fungal Genet. Biol."},{"key":"B74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.36.2.329-334.1998","article-title":"Candida dubliniensis: characteristics and identification","volume":"36","author":"Sullivan","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/viru.2.1.15002","article-title":"Differential virulence of Candida albicans and C. dubliniensis: a role for Tor1 kinase?","volume":"2","author":"Sullivan","year":"2011","journal-title":"Virulence"},{"key":"B76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.femsle.2005.09.015","article-title":"Candida dubliniensis: ten years on","volume":"253","author":"Sullivan","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"B77","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1567-1356(03)00240-X","article-title":"Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans","volume":"4","author":"Sullivan","year":"2004","journal-title":"FEMS Yeast Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/EC.05085-11","article-title":"Coevolution of morphology and virulence in Candida species","volume":"10","author":"Thompson","year":"2011","journal-title":"Eukaryotic Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","article-title":"Oropharyngeal candidiasis in the era of antiretroviral therapy","volume":"109","author":"Thompson","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"B80","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/21505594.2016.1197444","article-title":"Targeting Candida albicans filamentation for antifungal drug development","volume":"8","author":"Vila","year":"2017","journal-title":"Virulence"},{"key":"B81","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus","volume":"41","author":"White","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B82","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.41.7.1488","article-title":"The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans","volume":"41","author":"White","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/S1359-6446(05)03632-9","article-title":"Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development","volume":"10","author":"Whitebread","year":"2005","journal-title":"Drug Discov. Today"},{"key":"B84","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1524-4733.2002.51108.x","article-title":"The direct cost and incidence of systemic fungal infections","volume":"5","author":"Wilson","year":"2002","journal-title":"Value Health"},{"key":"B85","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0891-5520(05)70363-9","article-title":"Nosocomial Candida. Epidemiology, transmission, and prevention","volume":"11","author":"Wright","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"B86","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/mmi.13247","article-title":"Regulation of filamentation in the human fungal pathogen Candida tropicalis","volume":"99","author":"Zhang","year":"2016","journal-title":"Mol. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T11:42:35Z","timestamp":1604576555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":86,"alternative-id":["10.3389\/fcimb.2018.00227"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00227","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,10]]},"article-number":"227"}}